J J Puetz

Summary

Affiliation: Saint Louis University
Country: USA

Publications

  1. doi request reprint Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect
    John Puetz
    Department of Pediatrics, Division of Hematology Oncology, Saint Louis University, Cardinal Glennon Children s Medical Center, St Louis, MO 63104, USA
    J Pediatr 160:210-215.e1. 2012
  2. ncbi request reprint High-titre factor VIII inhibitor in two children with mild haemophilia A
    J J Puetz
    Hemophilia Treatment Center, Cardinal Glennon Children s Hospital, St Louis University Health Sciences Center, St Louis, MO 63104, USA
    Haemophilia 7:215-9. 2001
  3. ncbi request reprint Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center
    J Puetz
    Division of Pediatric Hemostasis, Department of Pediatrics, St Louis University Health Sciences Center, St Louis, MO 63104, USA
    Haemophilia 10:87-93. 2004
  4. ncbi request reprint Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies
    John Puetz
    Hemophilia Treatment Center, 1465 S Grand, St Louis Missouri, 63104, USA
    Thromb Haemost 91:819-21. 2004
  5. ncbi request reprint Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literature
    John Puetz
    Division of Hemostasis, Department of Pediatrics, St Louis University Health Sciences Center, Cardinal Glennon Children s Hospital, 1465 S Grand, St Louis, MO, USA
    J Pediatr Hematol Oncol 27:323-5. 2005
  6. doi request reprint Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma
    John Puetz
    Division of Hematology Oncology, Department of Pediatrics, Saint Louis University, SSM Cardinal Glennon Children s Medical Center, St Louis, Missouri 63104, USA
    Pediatr Blood Cancer 53:1074-8. 2009
  7. doi request reprint Fresh frozen plasma and recombinant factor VIIa use in neonates
    John Puetz
    Division of Hematology Oncology, Department of Pediatrics, Saint Louis University, SSM Cardinal Glennon Children s Medical Center, South Grand, St Louis, MO 63104, USA
    J Pediatr Hematol Oncol 31:901-6. 2009
  8. pmc Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
    John Puetz
    Department of Pediatrics, Saint Louis University, St Louis, Missouri, USA
    Drug Des Devel Ther 4:127-37. 2010

Detail Information

Publications8

  1. doi request reprint Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect
    John Puetz
    Department of Pediatrics, Division of Hematology Oncology, Saint Louis University, Cardinal Glennon Children s Medical Center, St Louis, MO 63104, USA
    J Pediatr 160:210-215.e1. 2012
    ..To determine the pattern, prevalence and potential complications of fresh frozen plasma (FFP) use in US pediatric hospitals from 2002-2009...
  2. ncbi request reprint High-titre factor VIII inhibitor in two children with mild haemophilia A
    J J Puetz
    Hemophilia Treatment Center, Cardinal Glennon Children s Hospital, St Louis University Health Sciences Center, St Louis, MO 63104, USA
    Haemophilia 7:215-9. 2001
    ..We wish to report our experience with an additional two children with mild haemophilia A and high titre inhibitors, and offer suggestions for the management of these children...
  3. ncbi request reprint Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center
    J Puetz
    Division of Pediatric Hemostasis, Department of Pediatrics, St Louis University Health Sciences Center, St Louis, MO 63104, USA
    Haemophilia 10:87-93. 2004
    ..Given the toxicity of combination therapy, and natural history of hepatitis C infection in children, consideration of a liver biopsy to evaluate disease progression prior to considering antiviral medications is warranted...
  4. ncbi request reprint Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies
    John Puetz
    Hemophilia Treatment Center, 1465 S Grand, St Louis Missouri, 63104, USA
    Thromb Haemost 91:819-21. 2004
  5. ncbi request reprint Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literature
    John Puetz
    Division of Hemostasis, Department of Pediatrics, St Louis University Health Sciences Center, Cardinal Glennon Children s Hospital, 1465 S Grand, St Louis, MO, USA
    J Pediatr Hematol Oncol 27:323-5. 2005
    ..To date, all patients with Gardner-Diamond syndrome reported to have undergone platelet aggregation studies have had abnormal results...
  6. doi request reprint Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma
    John Puetz
    Division of Hematology Oncology, Department of Pediatrics, Saint Louis University, SSM Cardinal Glennon Children s Medical Center, St Louis, Missouri 63104, USA
    Pediatr Blood Cancer 53:1074-8. 2009
    ..The prevalence of thrombotic events in these neonates is completely unknown. This study was initiated to determine the risk of thrombotic events associated with rFVIIa use in neonates...
  7. doi request reprint Fresh frozen plasma and recombinant factor VIIa use in neonates
    John Puetz
    Division of Hematology Oncology, Department of Pediatrics, Saint Louis University, SSM Cardinal Glennon Children s Medical Center, South Grand, St Louis, MO 63104, USA
    J Pediatr Hematol Oncol 31:901-6. 2009
    ..Little recent data are available describing fresh frozen plasma (FFP) use in neonates. The purpose of this study was to determine the outcomes of FFP transfusions in neonates...
  8. pmc Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
    John Puetz
    Department of Pediatrics, Saint Louis University, St Louis, Missouri, USA
    Drug Des Devel Ther 4:127-37. 2010
    ..5 million doses of rFVIIa have been given to inhibitor patients, with an excellent efficacy and safety record. Because of its short half-life, alternative means of dosing and infusing rFVIIa have been explored and are reviewed here...